Correlation of H2 O2 , pH and nitrite/nitrate in exhaled breath condensate and systemic inflammatory parameters during and after acute COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 349s Year: 2005
Oxidative stress evaluation in exhaled breath condensate (EBC) vs induced sputum (IS) in the assessment of lung diseases Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007
Pretreatment levels of VEGF and 8-isoprostane in exhaled breath condensate (EBC) and serum of lung cancer patients Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Physiological correlations between urea and total protein in breath condensate, bronchoalveolar lavage fluid and serum (animal model) Source: Eur Respir J 2001; 18: Suppl. 33, 366s Year: 2001
Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
Increased lactate concentrations in exhaled breath condensate (EBC) in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
Supplementation with antioxidants in Down syndrome: the effects on exhaled breath condensate (EBC) and serum Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007
TNF-α in exhaled breath condensate and in serum of scleroderma patients Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003
Lactate, pH and angiogenetic markers in exhaled breath condensate correlate with outcome and disease severity in patients with acute lung injury Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011
The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Exhaled breath condensate nitrite as a marker for lung injury involving alveolar (over) distension Source: Eur Respir J 2002; 20: Suppl. 38, 228s Year: 2002
The 3-nitrothyrozine and total nitrate/nitrite (TNN) levels in exhaled breath condensate (EBC) in patients with bronchial asthma (BA) Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010
Ammonia and urea in the exhaled breath condensate (EBC) and in corresponding blood samples Source: Eur Respir J 2002; 20: Suppl. 38, 482s Year: 2002
N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 13s Year: 2005
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009
Increased concentration of hydrogen peroxide (H2 O2 ) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001
The concentration of total protein in exhaled breath condensate (EBC) depends on various variables of ventilation Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006